Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

Show other versions (1)

Bibliographic Details
Main Authors:	Anthony, D, Campbell, S, Dickens, A, Checa, B, Kersemans, V, Seneca, N, Balazs, M, Leppert, D
Format:	Conference item
Published:	2012

Similar Items

Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
by: Leppert, D, et al.
Published: (2012)

Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
by: Anthony, D, et al.
Published: (2014)

Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
by: Seneca, N, et al.
Published: (2012)

Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
by: Anthony, D, et al.
Published: (2014)

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
by: Anthony, D, et al.
Published: (2009)

Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
by: Anthony, D, et al.
Published: (2014)

Alport’s syndrome with focal segmental glomerulosclerosis lesion – Pattern to recognize
by: Afnan A Alsahli, et al.
Published: (2018-01-01)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
by: Yeo, T, et al.
Published: (2022)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
by: Yeo, Tianrong, et al.
Published: (2022)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
by: Tianrong Yeo, et al.
Published: (2022-10-01)

In Vivo micro-PET Imaging Demonstrates Diminished Microglial Activation after FTY720 Treatment in an Animal Model of Multiple Sclerosis
by: Airas, L, et al.
Published: (2013)

Incidental Focal Spleen Lesions: Integrated Imaging and Pattern Recognition Approach to the Differential Diagnosis
by: Antonio Corvino, et al.
Published: (2023-07-01)

Microvascular flow imaging to differentiate focal hepatic lesions: the spoke-wheel pattern as a specific sign of focal nodular hyperplasia
by: Aladár David Rónaszéki, et al.
Published: (2023-01-01)

Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
by: Ione O. C. Woollacott, et al.
Published: (2020-08-01)

Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama
by: Marine Cascarino, et al.
Published: (2021-07-01)

Comparison of MRI signatures in pattern I and II multiple sclerosis models.
by: Serres, S, et al.
Published: (2009)

Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy
by: A. Stabile, et al.
Published: (2020-07-01)

In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
by: Airas, L, et al.
Published: (2015)

Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
by: Michael Haimerl, et al.
Published: (2014-01-01)

Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy
by: A. Stabile, et al.
Published: (2020-10-01)

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots
by: Robert Marschallinger, et al.
Published: (2021-01-01)

Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
by: Ana Navarro, et al.
Published: (2018-08-01)

Significance of the focal brain lesion in development of vestibular and acoustical disturbances in patients with multiple sclerosis
by: I M Kirichenko, et al.
Published: (2011-12-01)

Microglial involvement in neuroplastic changes following focal brain ischemia in rats.
by: Alexandre Madinier, et al.
Published: (2009-12-01)

Partial volume-aware assessment of multiple sclerosis lesions
by: Mário João Fartaria, et al.
Published: (2018-01-01)

Molecular imaging of microglial activation in amyotrophic lateral sclerosis.
by: Philippe Corcia, et al.
Published: (2012-01-01)

Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation
by: S. K. Vainio, et al.
Published: (2019-05-01)

Reactivation of a focal EAE lesion by a systemic inflammatory response
by: Serres, S, et al.
Published: (2007)

Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique
by: Carmen Tur, et al.
Published: (2022-01-01)

Patterns and predictors of language representation and the influence of epilepsy surgery on language reorganization in children and young adults with focal lesional epilepsy.
by: Carmen Barba, et al.
Published: (2020-01-01)

Mechanisms underlying different onset patterns of focal seizures.
by: Yujiang Wang, et al.
Published: (2017-05-01)

Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain
by: Molly E. V. Swanson, et al.
Published: (2023-04-01)

CONTRIBUTION OF PERIPHERAL IL-1BETA EXPRESSION IN THE SYSTEMIC REACTIVATION OF FOCAL MOG-EAE LESIONS IN RAT BRAIN
by: Serres, S, et al.
Published: (2009)

Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain
by: Serres, S, et al.
Published: (2009)

Approaching focal liver lesions Actitud a seguir ante una lesión hepática focal
by: F. Pons, et al.
Published: (2004-08-01)

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
by: Stefan Gingele, et al.
Published: (2018-12-01)

Distribution of CD8 and CD20 lymphocytes in chronic periapical inflammatory lesions
by: Philippi Christine Kalvelage, et al.
Published: (2003-01-01)

Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models
by: Maria Concetta Geloso, et al.
Published: (2021-03-01)

Focal Cortical Dysplasia with hippocampal sclerosis
by: Devendra Jadav, et al.
Published: (2023-01-01)

Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?
by: Lee, M, et al.
Published: (1999)